TITLE:
2 Doses of an Approved Drug Being Studied for a New Indication for the Prevention of Postoperative Nausea and Vomiting (0869-091)

CONDITION:
Postoperative Nausea and Vomiting

INTERVENTION:
MK0869, aprepitant

SUMMARY:

      The purpose of this study is to assess the safety and efficacy of 2 doses of an approved
      drug for a new indication in the prevention of postoperative nausea and vomiting in patients
      receiving general anesthesia for open abdominal surgery requiring overnight hospital stay.
    

DETAILED DESCRIPTION:

      The duration of treatment is 4 weeks.
    

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria:

          -  Patient is at least 18 years of age.

          -  Patient is scheduled to undergo open abdominal surgery requiring overnight hospital
             stay (24-hour hospital stay after end of surgery).

          -  Patient is scheduled to receive general anesthesia.

          -  Patient is scheduled to receive postoperative opioids.
      
